M. Braun

An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence

R. Wäsch, G. Ihorst, M. Engelhardt, 2022, Haematologica.

Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors

R. Wäsch, M. Engelhardt, C. Greil, 2021, Cancers.

The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans

Joe D. Cohen, O. Ofori-Anyinam, P. Moris, 2009, Human vaccines.

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

M. Greene, M. Braun, Sharon K. Gershon, 2002, Arthritis and rheumatism.